Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Medtronic
Dow
McKinsey
McKesson

Last Updated: June 27, 2022

Investigational Drug Information for Putrescine


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Putrescine?

Putrescine is an investigational drug.

There have been 7 clinical trials for Putrescine. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Hemorrhage, and Periodontitis. The leading clinical trial sponsors are National Cancer Institute (NCI), University Hospital, Bordeaux, and Food and Drug Administration (FDA).

There are one hundred and ninety-one US patents protecting this investigational drug and twenty-seven international patents.

Recent Clinical Trials for Putrescine
TitleSponsorPhase
Effect of Probiotic Lozenges on Halitosis in Patients With Chronic PeriodontitisBioGaia ABPhase 4
Effect of Probiotic Lozenges on Halitosis in Patients With Chronic PeriodontitisUniversity of ZagrebPhase 4
Feasibility Study on Stem Cells Sensitivity AssayAssociazione Oncologia TraslazionalePhase 2

See all Putrescine clinical trials

Clinical Trial Summary for Putrescine

Top disease conditions for Putrescine
Top clinical trial sponsors for Putrescine

See all Putrescine clinical trials

US Patents for Putrescine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Putrescine See Plans and Pricing Acylated amine compounds which are useful fungicigal agents Roussel Uclaf (Paris, FR) See Plans and Pricing
Putrescine See Plans and Pricing Liquid developer for electrostatic photography Fuji Photo Film Co., Ltd. (Kanagawa, JP) See Plans and Pricing
Putrescine See Plans and Pricing Process for producing unsaturated mono and dicarboxylic acid imide compound Matsushita Electric Works Ltd. (Osaka, JP) See Plans and Pricing
Putrescine See Plans and Pricing Cyclic hydrocarbons with an aminoalkyl sidechain The Upjohn Company (Kalamazoo, MI) See Plans and Pricing
Putrescine See Plans and Pricing Composite dental cement composition containing a lanthanide series compound Essential Dental Systems, Inc. (South Hackensack, NJ) See Plans and Pricing
Putrescine See Plans and Pricing Dipyridoxyl phosphate chelating compound intermediates useful as NMRI contrast agents Salutar, Inc. (Sunnyvale, CA) See Plans and Pricing
Putrescine See Plans and Pricing Thermosetting polyurethane structural adhesive compositions and processes for producing the same Rheox, Inc. (Hightstown, NJ) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Putrescine

Drugname Country Document Number Estimated Expiration Related US Patent
Putrescine Canada CA1268332 2006-10-23 See Plans and Pricing
Putrescine Canada CA1328060 2006-10-23 See Plans and Pricing
Putrescine Germany DE3786255 2006-10-23 See Plans and Pricing
Putrescine Germany DE3854011 2006-10-23 See Plans and Pricing
Putrescine Germany DE3855935 2006-10-23 See Plans and Pricing
Putrescine European Patent Office EP0283048 2006-10-23 See Plans and Pricing
Putrescine European Patent Office EP0288568 2006-10-23 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Medtronic
Dow
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.